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1.     SUMMARY 
Several proteins are localized in two cellular compartments at the same 
time with special targeting signals that are localized at the N-terminal 
domain. Among these protein, the isoform 3 of the Na
+
/Ca
2+
 exchanger 
(NCX3) family has been found on both plasma membrane and outer 
mitochondrial membrane (OMM), where it plays an important role in the 
maintenance of cytosolic and mitochondrial Ca
2+
 homeostasis. In 
particular,  mitochondrial NCX3 takes part in mitochondrial Ca
2+
 efflux 
from the OMM, promoting cell survival during hypoxia, through an 
AKAP121-anchored signaling complex. Interestingly, the amount of 
NCX3 localized on the OMM of neurons decreases during oxygen 
glucose deprivation and is restored after re-oxygenation (OGD-Rx), 
suggesting the presence of a regulatory mechanism the subcellular 
sorting of NCX3. The aim of the present study was to investigate the 
molecular determinants and the mechanism regulating the subcellular 
sorting of NCX3 on mitochondria. 
Results obtained showed that the silencing of either translocase of outer 
mitochondrial membrane (TOM), TOM22 or TOM70, decreased the 
amount of NCX3 on mitochondria suggesting that these two 
mitochondrial import receptors are involved in the recognition and 
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transport of this antiporter on the OMM. By contrast, the silencing of the 
other mitochondrial import receptor, TOM20, did not show affect the 
subcellular localization of the antiporter.  
By using  a bioinformatics approach, we identified some putative regions 
of NCX3 that might contain a mitochondrial localization signal. On the 
basis of these data, we analyzed the mitochondrial fraction of baby 
hamster kidney (BHK) cells stably transfected with several chimeric 
proteins containing the sequences of NCX3 and NCX1 and NCX3 
mutants.  Mitochondrial extraction of these chimeric proteins revealed 
that NCX3 is provided with three independent regions containing the 
molecular determinants for its subcellular localization on OMM and that 
are localized in the C-terminal region of the cytosolic f-loop (718-756 
aa), in the alpha1 (109-133 aa) and alpha2 (788-829 aa) sequences.  
Furthermore, we generated several site-directed mutants of NCX1 in 
which single amino acids in the alpha1 or alpha2 region was substituted 
with the corresponding one present in NCX3. Results showed that, 
chimeric proteins provided with the backbone of NCX1 and amino acids 
regions 109-133, 718-787, 788-829 of NCX3 were localized on 
mitochondria, supporting the conclusion that there are multiple 
mitochondrial localization signals spread along the protein. 
Summary 
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Another aspect that emerged from these results is the proximity of the 
mitochondrial localization signal and the N-terminal signal peptide for 
plasma membrane in NCX3 sequence as it occurs in other proteins with 
multiple subcellular localizations. In fact, post-translational 
modifications, i.e. PKA phosphorylation or cleavage of the N-terminus 
close to the mitochondrial localization sequence, can regulate the protein 
topology inside the cell. In this regards, we excluded the participation of 
PKA phosphorylation in NCX3 topology on  mitochondria,  since the 
specific inhibitor of PKA phosphorylation, KT5720, did not influence 
the distribution of the antiporter between the plasma membrane and 
mitochondria. On the other hand, the removal of the signal peptide at the 
N-terminus (NCX3Δ2-31),  increased the amount of the exchanger on 
mitochondria, supporting the hypothesis that the cleavage of this signal 
peptide, occurring during the antiporter synthesis, can participate in the 
regulation of NCX3 topology under physiological or pathophysiological 
conditions. 
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2   INTRODUCTION 
 
2.1      Mitochondrial Calcium Homeostasis 
Mitochondria are highly specialized organelles, crucial for ensuring 
numerous fundamental physiological processes, such as energy 
conversion, redox balance, modulation of calcium (Ca
2+
) signaling and 
important biosynthetic pathways. In eukaryotic cells, the ATP 
production is functionally coupled to metabolic demands and the cells 
are able to adapt oxidative respiration by activating of matrix 
dehydrogenases in response to changes in extracellular 
microenvironment and metabolic nutrient availability (1). The 
mitochondrial volume, number and distribution within the cells are 
strictly controlled according to local energy demands and in cells of 
highly metabolic tissues such as muscle, liver and central nervous 
system, the trafficking of mitochondria is critical. In particular, the brain 
uses over 95% of the ATP of the CNS (2) and the mitochondria 
distribution within neurons is concentrated in regions associated to a 
high metabolic activity, such as synapses, node of Ranvier and 
myelination/demyelination interfaces (3; 4; 5; 6). The 50-60% of total 
brain ATP is used to the generation, processing and transmission of 
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neural impulses that is conditional to the maintaining of ion gradients of 
sodium (Na
+
), potassium (K
+
) and calcium (Ca
2+
) across the plasma 
membrane. 
Besides performing oxidative phosphorylation, mitochondria are able to 
sense and shape calcium transients, thus controlling cytosolic Ca
2+
 
signals and Ca
2+
-dependent proteins. Indeed, despite in the past was 
believed that mitochondria playing only a marginal role in physiological 
intracellular Ca
2+
 homeostasis, whereas the Ca
2+
 affinity of the 
mitochondrial transporters is low, it has been recently well established 
that these organelles have a huge capacity to accumulate calcium and 
operate a key role in the intracellular calcium signaling (7).  
Calcium homeostasis is fundamental for cell; it carries information to 
virtually all processes important to cell metabolism, proliferation and 
differentiation but also transmits signals that promote the programmed 
demise of cells (8; 9). The maintenance of mitochondrial calcium 
homeostasis is an important requirement ensuring mitochondrial 
function. The energy demand and calcium homeostasis are strictly 
correlated each other, then the ATP-utilizing cellular processes that are 
triggered by calcium are regulated by energy suppliers under control of 
calcium itself (10). Indeed, Ca
2+
 sensitive dehydrogenases can regulate 
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oxidative phosphorylation and ATP synthesis during times of high 
cellular demand (11; 12). Moreover, the presence of high levels of Ca
2+
 
in the mitochondrial matrix is necessary for the activity of mitochondrial 
enzymes (13). However, when the calcium into the mitochondria 
overcomes its storage capability, as happens in pathological conditions, 
such as in neuronal anoxia or neurodegenerative impairments, it results 
in a subsequent increase in reactive oxygen species free radical 
production (ROS) in order to face the rapid rise of [Ca
2+
]i. The result of 
this process is the damage of the inner mitochondrial membrane (IMM) 
and the oxidation of the proteins involved in oxidative phosphorylation, 
in proton pumping and in ATP production (14). Another consequence of 
the rise of mitochondrial calcium concentration is the increase of inner 
mitochondrial membrane permeability that occurs in the opening of 
mitochondrial permeability transition pore (mPTP). This event causes 
the release of cytocrome C, that in turn causes an impairment of cellular 
respiration and the activation of programmed cell death (15; 16). As a 
consequence of this cascade events, mitochondrial membrane 
permeability and ATP production are irreversibly affected and, 
moreover, there is an impairment of the mitochondrial capability to 
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regulate intracellular calcium concentration in response to stress stimuli 
(17), thus cells are intended to die. 
 
 
 
 
 
Ca
2+ 
mitochondrial traffic across the mitochondrial inner membrane 
(IMM) takes place by two pathways. The Ca
2+
 influx pathway is 
represented by the mitochondrial calcium uniporter (MCU), a protein 
localized in the inner membrane, which markedly enhances 
mitochondrial Ca
2+
 uptake into the mitochondrial matrix. MCU activity 
is driven by an electrochemical potential across the inner mitochondrial 
Fig. 1    Mitochondrial calcium homeostasis mechanisms 
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membrane, usually estimated at -200, -180 mV and generated either by 
the respiratory chain activity and by ATP hydrolysis (18; 19). The Ca
2+
 
efflux pathway is catalyzed by antiporters that drive Ca
2+
 out of the 
mitochondrial matrix in exchange with either Na
+
 or H
+
 (20). In 
particular, two main antiporters have been characterized in the 1970s, the 
Na
+
/Ca
2+
 exchanger (NCLX or NCXmit), mostly expressed in excitable 
cells (muscle and brain) (21), and a H+/Ca
2+
 exchanger (HCXmit), that 
represents the prevailing route in most other tissues (23). 
NCLX was the first mitochondrial antiporter identified and localized on 
mitochondria cristae (24). It is the main mechanism responsible for the 
maintaining of  Na
+
-dependent Ca
2+
 efflux from the inner mitochondrial 
membrane. However, when the intramitochondrial Ca
2+
 rises or there is a 
mitochondrial membrane depolarization, the mPTP channel also 
participates in the Ca
2+
 efflux from the inner membrane of mitochondria. 
The physiological role of Ca
2+
-induced permeability is still unclear, the 
opening of a large pore in the IMM would allow maximal Ca
2+
 release 
even for very small [Ca
2+
] gradients, indeed PTP has also been proposed 
to represent a way of clearing the mitochondrial matrix of damaged or 
unneeded molecules, for removing damaged mitochondria or inducing 
apoptosis (21). Recently, OMM has also been recognized as a player in 
Introduction 
 
12 
 
the mitochondrial Ca
2+
 cycling. Indeed, it serves as an important 
permeability barrier to both Ca
2+
 uptake and efflux. Despite this, the 
voltage dependent anion channel (VDAC) located on the OMM, plays a 
relevant role in the regulation of Ca
2+
 permeability, thus favoring the 
activity of the specific transport systems of the inner membrane (25).  
The maintenance of a healthy mitochondrial population is essential to 
avoid the impairment of the processes they regulate. The cellular Ca
2+
 
deregulation, leading to mitochondrial calcium overload and cell death 
trough PTP opening, followed by mitochondrial swelling, has been 
described as final step for many neurodegenerative diseases. Thus, the 
escape of Ca
2+
 control is thought to be critically important for triggering 
the cell death after a traumatic brain injury as well as in several 
neurodegenerative disorders such as Alzheimer's, Parkinson's, 
Huntington's diseases and Amyotrophic Lateral Sclerosis (ALS).  
 
 
2.2     The Na
+
/Ca
2+
 exchanger (NCX)  
 
The Na
+
/Ca
2+
 exchanger (NCX) is an ion transporter that plays a crucial 
role in in the function and regulation of several cellular activities. NCX 
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belongs to the Ca
2+ 
cation antiporter superfamily (CaCA) and consists of 
10 transmembrane (TM) segments (26). NCX was discovered and 
characterized in the late 1960s, when Baker et al. (27), Reuter and Seitz 
(28), and Martin and De Luca (29) realized the presence of counter 
transport mechanism that exchanged Na
+
 and Ca
2+
 ions across the 
plasma membrane of different excitable and non excitable cells. 
However, the most crucial advancement in NCX research was made in 
1988 (30) and 1990 (31) when Philipson and his colleagues purified and 
cloned the first isoform of this antiporter: NCX1. Remarkably, few years 
later, the same group cloned NCX2 (32) and NCX3 (33), two isoforms 
selectively expressed in the brain and in the skeletal muscle whereas, in 
1999, it proposed a topological model of the NCX1 exchanger with 11 
TM domains (34). Only recently, it was demonstrated by solving the 
crystal structure of NCX from the archaebacterium Methanococcus 
jannaschii (NCX_Mj) (35) the 10 TM domains structure of NCX and it 
appears that this membrane topology is the same in mammalian NCX 
proteins (26). 
NCX is allosterically regulated by its substrates, Ca
2+
 and Na
+
, and by 
H
+
 (36; 37) and it can mediate Ca
2+
 and Na
+
 fluxes across the plasma 
membrane with a stoichiometry of 1:3, respectively (38). Depending on 
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the electrochemical gradient of [Ca
2+
], and [Na
+
], NCX catalyzes the 
influx or the extrusion of Ca
2+
, thus operating either in the forward 
mode, coupling the uphill extrusion of Ca
2+
 to the influx of Na
+
 ions, or 
in the reverse mode, mediating the extrusion of Na
+
 and the influx of the 
Ca
2+
 ions (36; 39). When [Ca
2+
]i rise and the cells require to return in 
resting conditions NCX is able to work in forward mode, coupling both 
the extrusion of Ca
2+
 to the influx of Na
+
 (40). Otherwise, under other 
physiological circumstances, when [Na
+
]i rise, or membrane 
depolarization occurs, the Na
+
/Ca
2+
 exchanger operates in reverse mode, 
thus mediating the extrusion of [Na
+
]i and the influx of Ca
2+  
ions (41; 
42).  
The NCX family by its participation to the regulation of intracellular 
concentration of Ca
2+
 and Na
+
 ions in excitable cells, has a relevant 
physiological function in the maintaining of cellular homeostasis. 
Indeed, the Na
+
/Ca
2+
 exchanger, in parallel with selective ion channels 
and ATP-dependent pumps, maintains the physiological cytosolic 
concentrations of these ions. NCX expression in all cell types is involved 
in many physiological events throughout the body. In this regard, NCX 
in muscle tissues is mostly known for its role in Ca
2+
 extrusion during 
muscle relaxation. Moreover, NCX is important in the cardiac 
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development, and its loss of function causes heart failure on the 
midterm. NCX is also required in skeletal and smooth muscle where it 
could possibly act as a modulator of the sarcoplasmic reticulum (SR) 
content. NCX is also implicated during brain development and 
neurotransmitter release. In non-excitable tissues, NCX carries out very 
diverse roles such as the Ca
2+
 reabsorption in the distal convoluted 
tubules of the kidney and the Na
+
 extrusion in erythrocytes and 
participates to the control of insulin release in pancreatic β-cells (43).  
 
 
2.3     Molecular Biology of NCX 
 
 
 
 
NH2
f-loop
COOH
CBD1 CBD2
2 3 4 5 6 7 8 91 10
a2
a1
Fig. 2   Molecular topology of NCX 
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In mammals three genes coding for the three different isoforms have 
been found: NCX1, NCX2 and NCX3. NCX1 gene is expressed 
ubiquitously in almost all mammalian cells including neurons, 
cardiomyocytes, skeletal and smooth myocytes. At the post-
transcriptional level, at least 17 NCX1 and 5 NCX3 proteins are 
generated through an alternative splicing of the primary nuclear 
transcripts (44; 45; 46; 47). These variants arise from a region of the 
large intracellular f loop and are encoded by six small exons defined A 
to F. These exons are used in different combinations in a tissue-specific 
manner (48), but to maintain an open reading frame, all splice variants 
must include either exon A or B, which are mutually exclusive (44). In 
the excitable tissues, such as those of the brain and heart, the variants are 
usually characterized by the presence of exon A, whereas kidney, 
stomach, and skeletal muscle tissues comprise NCX with exon B (48). 
The occurrence of two parallel genome duplications early in the 
vertebrate lineage gave rise to, most likely, four isoforms of NCX. The 
fourth isoform, NCX4, present in teleost, amphibian, and reptilian 
genomes, has been lost in birds and mammals during evolution (49). 
From this early duplication, NCX family conserved a strong homology 
of sequence of about 70% in mammals. The canine heart NCX1 is 
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composed of 938 amino acids and it has a theoretical molecular mass of 
120 kDa. NCX2 have been found only in the central nervous system 
(CNS), whereas NCX3 have been found in both CNS and skeletal 
muscle. These two gene products consist of 921 and 927 amino acids 
and are characterized by molecular masses of 102 and 105 kDa, 
respectively. In addition, NCX2 displays a 65% sequence identity with 
NCX1, whereas NCX3 possesses a 73% sequence identity with NCX1 
and 75% sequence identity with NCX2 (50). From the structural point of 
view, NCX amino-terminus is located in the extracellular space as well 
as the carboxyl terminus. The 10 TM segments can be divided into an N-
terminal hydrophobic domain, composed of the first five TMS (1-5), and 
into a C-terminal hydrophobic domain, composed of the last six TMS (6-
10). These two hydrophobic domains are important for the binding and 
the transport of ions. The first (1-5) TMS are separated from the last six 
(6-10) TMS through a large hydrophilic intracellular loop of 550 amino 
acids, named the f loop (51). Although the f loop is not implicated in Na
+
 
and Ca
2+
 translocation, it is responsible for the regulation of NCX 
activity elicited by several cytoplasmic messengers and transductional 
mechanisms, such as Ca
2+
 and Na
+
 ions, NO, phosphatidylinositol 4,5 
bisphosphate (PIP2), protein kinase C (PKC), protein kinase A (PKA), 
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and ATP. The f-loop has been reported to exert a Ca
2+
 regulatory 
function. Indeed, within this intracellular domain, two Ca
2+
 binding 
domain (CBD1 and CBD2) are found, that undergo conformational 
changes upon binding of Ca
2+
 and look very similar in the Ca
2+
 bound 
form, whereas in the absence of Ca
2+
, the domains show dramatic 
structural differences. At the N-terminal end of the f loop near the 
membrane lipid interface, an autoinhibitory domain, rich in both basic 
and hydrophobic residues, named exchange inhibitory peptide (XIP) 
(52), has been identified. Therefore, NCX isoforms are characterized by 
several peculiarities, in particular, the presence of α-repeats in the TM 
segments. The NCX protein amino acid sequence found between TMS2 
and TMS3 is called α1 repeat, whereas the one found between TMS7 and 
TMS8 is named α2 repeat. Both these regions are located on the opposite 
site of the membrane and include two segments composed of 12 and 9 
highly conserved residues separated by a non conserved segment of 18 
to 20 amino acids (53). The α-repeats allow for the ion translocation 
across the plasma membrane. These regions contain four cation-binding 
sites, that share several negatively charged ligands. Therefore, Ca
2+
 and 
Na
+
 binding sites cannot be occupied simultaneously, which confirms a 
ping-pong mechanism of translocation in which one Ca
2+
 and three Na
+
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ions are translocated sequentially in separate steps rather than 
simultaneously across the membrane. This mechanism implies the 
alternating access mechanism of Na
+
 and Ca
2+ 
on the NCX ion binding 
sites in the inward (cytosolic) and outward (extracellular) conformations. 
Extracellular Na
+
 and Ca
2+
 ions reach these binding sites by two 
passages specific for each cation. Less information is available on the 
inward-facing conformation of NCX.   
 
 
2.4     Mitochondrial Na
+
/Ca
2+ 
Exchanger 3 (mNCX3) 
By catalyzing Na
+
-dependent Ca
2+
 efflux, mitochondrial NCX3 plays a 
fundamental role in regulating mitochondrial Ca
2+
 homeostasis, 
oxidative phosphorylation and Ca
2+
 crosstalk among mitochondria, 
cytoplasm and the endoplasmic reticulum (ER). Whereby, the 
mitochondrial activity of NCX3 exerts a pivotal role under both 
physiological and pathophysiological conditions. Indeed, among NCX 
gene products, NCX3, is not inhibited by the low levels of intracellular 
ATP. Indeed, this isoform, thanks to the ATP-independence (54; 55), 
exerts a neuroprotective role in stroke (56) and in the ischemic 
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preconditioning (57). On the other hand, NCX3 also plays a relevant role 
in the spatial learning and memory processes where it contributes to 
presynaptic Ca
2+
 clearance and thus enhances synaptic plasticity of 
hippocampal neurons (58). Recently, NCX3 was also found on the outer 
mitochondrial membrane where it contributes to the Ca
2+
 efflux in 
collaboration with NCLX. In particular, the activity of the mitochondrial 
NCX3 is dependent from the interaction with the anchoring protein, 
AKAP121 (59). NCX3 also performs an interesting role during 
ischemia. Indeed, hypoxic conditions downregulates, where 
reoxygenation  increases, the amount of NCX3 on mitochondria (59), 
suggesting the presence of a regulation of the cellular sorting of NCX3. 
These data open a new perspective on NCX3 regulation that is based on 
it subcellular sorting under physiological or pathophysiological 
conditions. 
 
 
2.5      Bimodal targeting of precursor proteins 
Some proteins can be located in different subcellular compartments, such 
as plasma membrane and  mitochondria, guided by activation of bimodal 
targeting signals that produce a dual distribution between the subcellular 
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compartments. (60; 61). They may be distinguished two main groups 
based on the number of translation products that are generated. The first 
group of proteins, includes isoproteins generated by different translation 
products can be obtained by different paths that are based on two genes, 
two mRNAs from a single gene or two translation products from the 
same mRNA. The examples of isoproteins described in all this cases 
differ by the presence or absence of a targeting signal (60; 61). A second 
group is represented by proteins result of the translation of a single 
protein product that hides two targeting signals or a chimeric signal that 
can target the protein to different organelles (60; 61). Indeed, in contrast 
to the canonical mitochondrial targeting signal, which is considered to be 
a structural element that binds to chaperones and receptors facilitating 
the targeting, the chimeric signal is more dynamic. It targets the protein 
to mitochondria or ER depending upon the physiologic demand of the 
cell (60; 61). Recent proteomic studies of mitochondrial proteins suggest 
that more than 1000 proteins, many of which may lack canonical 
cleavable targeting signals, may be translocated to mitochondria. 
Interestingly, dual localized mitochondrial proteins are generally 
characterized by a lower probability of mitochondrial targeting 
(MitoProtII score) and a lower net charge compared to exclusive 
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mitochondrial proteins, thus, not only the N-terminal targeting signal but 
also by the entire protein properties (such as its net charge), mediate dual 
targeting of mitochondrial proteins (62; 63). Another important finding 
demonstrated that nearly one-third of the yeast mitochondrial proteins 
are also localized in other cellular compartments (63). Examples of 
proteins that are bimodally targeted include the catalytic subunit of 
protein kinase A (PKA) (64), Alzheimer's amyloid precursor protein 
(APP) (65), α-synuclein (66), protein kinase C (PKC) isoforms, the 
protein kinase B (PKB), proteins involved in oncogenesis and apoptosis 
including tumor protein 53 (p53), the nuclear factor kappa-light-chain-
enhancer of activated B cells (NFkB), the B-cell lymphoma XL (Bcl XL) 
and (Bcl2) 2 factors (67; 68), nuclear receptors such as estrogen receptor 
(E2), Thyroid hormone receptor  3 (T3), the glucocorticoid receptor  
(GR)  and others. The chimeric mitochondria targeting signal requires 
activation by post-translational modification, a sequence-specific 
processing by a cytosolic endoprotease or PKA-mediated 
phosphorylation (69; 70; 71). In the first mechanism, the nascent chain 
escapes the signal recognition particle (SRP) binding and it is cleaved by 
a cytosolic Serine protease in sequence-specific manner to activate the 
cryptic mitochondrial signal of the protein; this nascent chains that are 
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translated as membrane free proteins are translocated to mitochondria 
with the help of Hsp70 and Hsp90 chaperones (Fig 3). The endoprotease 
responsible for the activation of the N-terminal targeting signal of 
CYP1A1 is a member of the Ser-protease family (72). The processing of 
CYP1A1 is sequence specific, indeed both the core cleavage site 
(+32/+33) and the flanking amino acids (30-VRVTRT-35) are required 
for processing (72). Interestingly, this protease was also found to process 
p53 (PAGSR), GR (ILLDFSK), RXR (ASFTK), and CYP1B1 
(RLLRQR) which all carry Ser-protease consensus sites, shown in 
parentheses, and the processed form of each protein targets to 
mitochondria (72). 
 
 
Fig. 3    N-terminal cleavage mechanism (Avadhani et al., 2011) 
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In the second mechanism of bimodal protein targeting, the nascent chain 
can be phosphorylated by PKA on specific Serin residues, in turn, 
produce a recognizable mitochondrial targeting signal. In particular, 
when the nascent chains are not phosphorylated, SRP bind and guide the 
unfolded protein to ER membrane, whereas, under high PKA conditions, 
the serine-phosphorylation reduces the affinity of nascent chains for SRP 
and the protein can be recognized by Hsp70 and Hsp90 chaperones and 
imported in mitochondria (Fig. 4). An example of this mechanism is 
represented by the monooxygenases CYP2E1 and 2B1 that contain 
single PKA phosphorylation sites at Ser129 and Ser128, respectively. 
CYP2D6, instead, contains a high consensus PKA target site at Ser135, 
and potential sites of lower consensus at Ser148 and Ser217 (73; 74). On 
the other hand, PKA phosphorylation activity also regulates the import 
efficiency of mitochondria suggesting multiple regulatory mechanisms 
of the subcellular sorting. 
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2.6      Protein Import Pathways into Mitochondria 
Almost 99% of mitochondrial proteins are encoded by nuclear genes, 
including NCX3, thus they must be imported by several ATP-dependent 
translocases that recognize, translocate, and insert in the mitochondrial 
membrane the mitochondrial protein (Fig 5). In particular, mitochondrial 
proteins contain several mitochondrial localization signals and post-
translational modifications that allow their recognition. 
On the basis of the mitochondrial localization signals, mitochondrial 
proteins can be divided into two main classes. The first class of 
Fig. 4    PKA-mediated phosphorilation mechanism (Avadhani et al. ., 2011) 
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precursor proteins carry an N-terminal cleavable extensions, termed pre-
sequences, that are characterized by a stretch of hydrophobic and 
positively charged residues. The function of these cleavable extensions is 
to interact with the mitochondrial import receptors and direct the pre-
protein across both outer and inner membranes (75; 76). The second 
class of precursor proteins carry different internal targeting signals that 
are not cleaved in the mature form. These precursors have the same 
primary sequence, but not the same conformation, of the mature protein 
(76; 77). In particular, it is known that many outer membrane proteins 
display mitochondrial localization signals with an α-helical 
conformation, that are often flanked by positively charged residues. 
However, the majority of these non-cleavable precursor proteins contain 
quite distinct targeting signals at various positions within their primary 
structure. Indeed, these targeting sequences can be found at the amino 
terminus (signal anchor sequence), at the carboxy terminus (tail anchor) 
and in the middle of the proteins (77; 78; 79; 80; 81). The exact nature 
and targeting mechanisms of these internal signals are not clear. 
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On the basis of the mitochondrial signals nature, mitochondrial proteins 
can follow multiple insertion pathway into the mitochondrial membranes 
(Fig. 5). The outer mitochondrial membrane (TOM) complex represents 
the central entry gate for practically all nuclear-encoded mitochondrial 
proteins (Fig 6). 
 
 
 
 
 
Fig. 5    Mitochondrial targeting signals 
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TOM complex consists of seven different subunits that can be grouped 
into three categories: the receptors Tom20, Tom22, and Tom70; the 
channel-forming protein Tom40; and three small Tom proteins, Tom5, 
Tom6, and Tom7 (82; 83). Tom40 is an integral membrane protein with 
a β-barrel structure and is the central component of TOM. It forms the 
channel for pre-protein translocation across the outer membrane and is 
organized as an oligomer that forms two to three channels per TOM 
complex (84; 85). Three receptor proteins function as part of the TOM 
complex. Tom20 is the initial recognition site involved in recognizing 
the pre-sequence of a pre-protein (86) and transfers the pre-proteins to 
the central receptor Tom22. Tom70 forms the initial recognition site for 
Fig. 6    Mitochondrial protein sorting (Chacinska et al., 2009) 
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precursors of inner membrane metabolite carrier proteins, which carry 
multiple internal targeting signals; Tom70 transfers these precursor 
proteins to Tom22 (87; 83). From here, the precursors are inserted into 
the Tom40 channel. A typical pre-sequence has a length of about 10–30 
amino acid residues and forms an amphipathic α-helix. One half of the 
helix possesses a hydrophobic surface that is recognized by a binding 
groove within Tom20 (88), whereas the other half is positively charged 
and recognized by the receptor Tom22 (89). With the help of the small 
protein Tom5, the pre-protein is then transported to the general import 
pore (90) Tom40 (82). After translocation through the Tom40 pore, the 
pre-sequence binds to the intermembrane space domain of the receptor 
Tom22 (91). Tom40 itself does not simply form a passive pore but rather 
interacts with the pre-proteins in transit.  
Pre-proteins with cleavable pre-sequences, as NCX3, are thus guided 
across the outer membrane by a chain of binding sites, including the 
cytosolic receptors Tom20, Tom22, Tom5, the Tom40 translocation 
channel, and the intermembrane space domain of Tom22 (91; 92). The 
other small Tom proteins, Tom6 and Tom7, do not directly interact with 
precursor proteins but are required for the assembly and stability of the 
TOM complex (93). These precursors are usually synthesized without a 
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pre-sequence but contain multiple internal targeting signals (94; 95). Pre-
cursor proteins synthesized on cytosolic ribosomes are usually guided by 
cytosolic targeting factors or chaperones to the mitochondrial surface. 
Cytosolic chaperones, particularly heat shock proteins of the Hsp70 and 
the Hsp90 classes, bind these hydrophobic precursors and prevent their 
aggregation in the cytosol. The precursor chaperone complexes are 
recognized by the surface receptor Tom70, which possesses binding sites 
for both the precursor proteins and the chaperones (95; 96; 97; 98). 
Several Tom70 molecules simultaneously bind to one precursor 
molecule, most likely to prevent misfolding of the precursor, indeed 
carrier precursor proteins contain multiple internal targeting signals and 
induce Tom70 molecules to form oligomers (95). The binding of several 
Tom70 proteins is thought to prevent aggregation of the hydrophobic 
precursor. In an ATP dependent step, the chaperones are released and the 
precursor is then transferred, in a loop formation, into the TOM channel 
(95). The carrier precursors are then transferred to the import pore 
Tom40. In this transfer are involved also the other receptor proteins, 
Tom20 and Tom22, as well as Tom5. Even if the receptors Tom20 and 
Tom22 preferentially recognize pre-sequences, while Tom70 mainly 
interacts with hydrophobic precursor proteins carrying internal targeting 
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signals, the three mitochondrial import receptors show a partially 
overlapping specificity (99). Upon inactivation of one receptor, the other 
receptors can partially replace with its function. Interestingly, the 
precursors of outer membrane proteins that contain internal targeting 
signals mainly use the receptors Tom20 and Tom22. Based on the 
complexity of the protein structure, the interaction of the precursors 
proteins with TOM complex can be followed by participation of the 
sorting and assembly machinery (SAM) of the outer membrane. The 
precursors of outer membrane proteins that possess a complex topology 
with multiple β-strands (β-barrel proteins), such as porin and Tom40, are 
first imported via the TOM complex to the intermembrane space side 
(93) and, with the help of the small Tim proteins of the intermembrane 
space (100; 101), they are then passed on to the SAM (93) where they 
can be exported and integrated into the outer membrane (Fig. 7 A). 
Instead, outer membrane proteins with a relatively simple topology, such 
as with one transmembrane segment, only require the TOM machinery 
for insertion into the membrane (93). Another variation of outer 
membrane insertion was identified for proteins with several 
transmembrane α-helical segments. These precursors require the receptor 
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Tom70, that probably functions in a chaperone-like manner to transfer 
the precursors into the outer membrane (79) (Fig. 7 B). 
 
 
 
Fig. 7    Mitochondrial protein import of β-barrel (A) or α-helical  proteins (Chacinska 
et al., 2009) 
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3.    AIM OF THE STUDY 
 
NCX3, besides its plasma membrane localization, is also localized on 
mitochondria, where it plays an important role in the maintenance of 
cytosolic and mitochondrial Ca
2+
 homeostasis (59). Recent studies 
demonstrated that a number of proteins, as well as NCX3, have been 
shown to be present in multiple cellular sites and that this bimodal 
localization is regulated in response to the cell physiological demand 
trough the activation of special targeting signals that are localized at the 
N-terminal domain (60). NCX3 shows several peculiarities that make its 
mitochondrial localization even more interesting respect to the role of 
the exchanger in the maintenance of [Ca
2+
]i homeostasis and the 
prevention of cell death under oxygen-glucose deprivation conditions.  
Interestingly, results obtained in neurons exposed to oxygen-glucose 
deprivation (OGD) demonstrated that the amount of NCX3 localized on 
the OMM of neurons can change, suggesting the presence of a regulatory 
mechanism of the subcellular sorting of NCX3. Furthermore, since the 
hypothesis of a mechanism regulating the NCX3 localization could open 
a new perspective regards a possible connection between the role of 
NCX3 sorting within the cell and its neuroprotection function (59), the 
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aim of this study was to investigate the molecular determinants and the 
mechanism regulating the subcellular sorting of NCX3 on mitochondria.  
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4    MATERIALS AND METHODS 
 
4.1  Plasmids and site directed mutagenesis 
NCX1/NCX3 (193-445, 718-795, 788-829) or NCX3/NCX1 (143-167, 
168-226, 707-776, 777-818) chimeras were kindly provided by Takahiro 
Iwamoto of Fukuoka University (Iwamoto et al., 2004). 
NCX1/NCX3 718-780 chimera, the deletion mutant NCX3Δ2-31, and 
the fusion proteins including EGFP and CBD1 or CBD2 regions of 
NCX3, were obtained with QuikChange Lightning Site-Directed 
Mutagenesis Kit (Agilent Technologies).  
Briefly, NCX3
Δ2-31 
was obtained by engineering the plasmid pKCRH-
NCX3 and using primers pairs designed to remove 93 nucleotides 
sequence spanning from +3 to +96 referring to transcriptional start site 
(+1), of rat NCX3 cDNA (GenBank accession no. U53420). The fusion 
proteins EGFP-CBD1 and EGFP-CBD2, were obtained by subcloning 
part of rat NCX3 cDNA in a pEGFP-C2 vector (Clontech, USA). All 
mutants obtained were verified by sequencing both DNA strands 
(Primm, Milan, Italy). 
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4.2     Cell culture 
Untransfected baby hamster kidney (BHK) cells and BHK cells stably 
transfected with canine cardiac NCX1.1 and NCX3.3 were a generous 
gift from Dr. Kenneth D. Philipson (University of California, Los 
Angeles, CA). BHK cells were all grown on plastic dishes in a mix of 
Dulbecco’s modified Eagle’s medium and Ham’s F-12 medium (1:1) 
(Life technologies) supplemented with 5% FBS, 100 U/ml penicillin and 
100 mg/ml streptomycin (Sigma).  Cells were cultured in a humidified 
5% CO2 atmosphere and maintained at 37°C.  
 
4.3   DNA and siRNA transfection and pharmacological treatment 
All plasmids were transiently or stably co-transfected with pEGFP 
(Clontech), to verify the transfection efficiency, by using Lipofectamine 
2000 (Life Technologies, USA). For the selection of stable transfected 
BHK cells, 24 h after transfection 10µg/ml of G418 (Sigma) was added 
in the complete medium for 2 weeks, the medium was changed every 
two days.  
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For the silencing experiment, validated specific siRNAs from QIAGEN 
were used for the knockdown of Tom70 (Hs_TOMM70A_1), Tom20 
(Hs_TOMM20_5) and Tom22 (Hs_TOMM22_9). The siRNAs were 
transiently transfected twice with a time interval of 24 h for TOMM70, 
or 48 h for TOMM20 and TOMM22, in BHK cells with a final 
concentration of 250 pmol/ml by using Lipofectamine 2000 (Life 
Technologies). NCX3 cDNA was transfected after 12h of siRNA 
treatment. Cells were processed for Western blot 16h after transfection. 
PKA phosphorylation in BHK cells was inhibited with 1μM of KT5720 
in complete medium for 24 h.  
 
4.4    Mitochondrial extracts 
Mitochondrial extracts were obtained with differential centrifugations. 
Firstly, BHK cells were collected in a 15-ml falcon tube, after washing 
in phosphate-buffered saline medium (PBS), and incubated with 1 ml of 
trypsin solution per 10-cm plate. The trypsinization was stopped by 
adding 6 ml of growth medium, pelleted by centrifugation at 1000 rpm 
for 3 minutes and resuspended in 300 μl of ice cold homogenization 
buffer solution (Buffer A) containing the following (mM): 250 mannitol, 
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0.5 EGTA, 5 HEPES (pH 7.4), 1.5 MgCl2, 0.1% aprotinin, 0.7 mg/ml 
pepstatin, and 1 mg/ml leupeptin, and gently disrupted by passing ten 
times through a 26-gauge needle. The suspension was centrifuged at 
2000 g for 5 minutes at 4°C. After the first centrifugation, pellets, 
corresponding to the fraction containing membranes but not intracellular 
organelles including mitochondria, were separated and lysed with lysis 
buffer containing (mM): 20 Tris-HCl (pH 7.5), 10 NaF, 150 NaCl, 1 
PMSF, 1% Nonidet P-40, 1 Na3VO4, 0.1% aprotinin, 0.7 mg/ml 
pepstatin, and 1 ml/mg leupeptin, and kept on ice for 15 minutes. The 
supernatant, was centrifuged at 500 g for 5 minutes at 4°C. After this 
centrifugation the pellet was discarded, and the supernatant 
corresponding to the cytosolic fraction containing the organelles, was 
further centrifuged at 19,000 g for 10 minutes at 4°C in order to separate 
the mitochondrial from the cytosolic fraction. Supernatants (cytosol) 
were then removed and assessed for protein content. Next, the pellets 
containing mitochondria were lysed in 50 μl of the same lysis buffer 
mentioned above and kept on ice for 15 minutes. Finally, samples were 
purified again by centrifugation (18,000 g, 10 minutes) and supernatants 
(mitochondria or membranes) were assessed for protein content by 
Bradford’s assay (Bradford, 1976). The three fractions obtained, 
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membranes, mitochondria and cytosol, were used for Western blotting. 
All the procedure was carried out at 4°C to minimize the action of 
proteases and phospholipases. The purity of the mitochondrial 
preparation was assessed by evaluating the expression of the proteins 
VDAC-1 and tubulin, or actin. 
 
4.5    Western blotting  
20 μg of protein samples were analyzed on 8% SDS-PAGE and 
electrotransferred to Hybond ECL nitrocellulose paper (Amersham). 
Membranes were first blocked with 5% non-fat dry milk in 0.1% Tween-
20 (TBS-T; 2 mM Tris–HCl, 50 mM NaCl, pH 7.5) for 2 hours at room 
temperature. They were then incubated overnight at 4°C in the blocked 
buffer using the appropriate antibodies: 1:1000 anti-NCX1 (rabbit 
polyclonal antibody, Swant), 1:5000 anti-NCX3 (rabbit polyclonal 
antibody, Swant), 1:500 anti-GFP (mouse monoclonal antibody, 
Abcam), 1:1000 anti-TOMM70 (mouse monoclonal antibody, Santa 
Cruz BT), 1:500 anti-TOMM20 (mouse monoclonal antibody, Abcam), 
1:500 anti-TOMM22 (mouse monoclonal, Abcam), 1:1000 CREB 
(mouse monoclonal antibody, Cell Signaling), 1:1000 p-CREB (rabbit 
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polyclonal, Millipore) and subsequently incubated with the secondary 
antibodies for 1 hour (1:5000; Amersham). Immunoreactive bands were 
detected with the ECL kit (Amersham). Discrimination among the 
distinct types of extracts was ensured by detection of the endogenous 
protein tubulin, or actin, (localized on plasma membrane), with 
respectively 1:5000 mouse polyclonal antibody anti-α-tubulin (Sigma) or 
1:1000 mouse polyclonal antibody anti-β-actin (Sigma), and VDAC with 
1:1000 mouse polyclonal antibody anti-VDAC (Santa Cruz BT) 
(localized on the outer mitochondrial membrane). 
 
4.6    Statistical analysis 
Data were generated from a minimum of three independent experiments. 
Data are expressed as mean ± SEM. Statistical analysis among means 
were determined by Student’s t test or ANOVA followed by Student-
Newman-Keuls test. The threshold for statistical significance data was 
set at p<0.05. 
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5 RESULTS 
 
5.1    Analysis of subcellular localization of NCX3/NCX1 chimeras 
Western blot experiments on mitochondrial and plasma membrane 
fractions obtained from BHK cells stably transfected with NCX1 or 
NCX3 were firstly performed to validate the differential protein 
extraction methodology. Results showed the localization of NCX1 on 
plasma membrane, and the dual localization of NCX3 on both plasma 
membrane and mitochondria (Fig. 8). 
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Fig. 8  Western blot of differential extraction of plasma membrane, cytosolic and 
mitochondrial proteins from BHK cells stably expressing NCX1 or NCX3. Tubulin 
and VDAC immunosignals were used to verify the purity of samples. 
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Plasmids expressing NCX3/NCX1 143-167, 168-226, 707-776, 777-818 
chimeras (Fig. 9) were stably transfected in BHK cells and then analyzed 
for their subcellular localization. The results showed the presence of the 
proteins on both plasma membrane and mitochondria (Fig. 10). 
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Fig.9   Topologies of chimeric proteins with NCX3 (in red) and NCX1 (in 
yellow) amino acid sequences. Signal peptide sequence is dashed (in grey) 
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5.2    Analysis of subcellular localization of NCX1/NCX3 chimeras 
The bioinformatics analysis of NCX3 sequence showed the regions with 
low sequence homology between NCX1 and NCX3. These regions were 
used to calculate the relative probability to contain mitochondrial 
targeting peptides (mTPs) by using TargetP1.1 software (Table 1). 
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Fig. 10  Western blot of differential protein extracts from BHK cells stably 
expressing  NCX3/NCX1 chimeric proteins. The purity of mitochondrial 
preparation was validated observing the absence of tubulin signal and the 
presence of VDAC signal. 
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On the basis of this information, we designed NCX1/NCX3 chimeras, 
where several regions of NCX1 (109-133, 193-445, 446-718, 718-787, 
788-829) were replaced with the same corresponding regions of NCX3. 
Results showed that the substitution of the region 109-133 of NCX1 with 
the corresponding region of NCX3 localized the chimeric protein on 
mitochondria (Fig. 11).  By contrast, the substitution of the region 788-
829 of NCX1 with the corresponding region of NCX3 did not localize 
the chimeric protein on mitochondria (Fig. 11).   
 
Domain Region of NCX3 Sequence Length (aa)
Relative Probability 
(A.U.)
N-Terminal
1  – 109 109 58
109 – 133 25 86
133 – 192 59 63
193 – 445 242 66
Cytosolic loop 446 – 717 235 51
C-Terminal
718 – 787 68 67
788 – 829 42 61
830 – 927 147 10
Table.1 Results of the relative probability (in arbitrary units A.U.) to contain 
mitochondrial targeting peptides (mTPs) in the N-terminal, C-terminal and cytosolic 
domains of NCX3. 
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Furthermore, NCX1/NCX3 chimeras in which regions 718-795 or 788-
829 of the C-terminal domain of NCX1 was substituted with the 
corresponding region of NCX3 displayed a subcellular localization 
forboth mitochondria and plasma membrane (Fig. 12).  
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Fig. 11  Western blot of differential protein extracts from BHK expressing the chimeric 
proteins NCX1/NCX3 109-133 or NCX1/NCX3 193-445. 
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Since the region 718-795 was wide, another smaller region (718-780) 
corresponding to a portion of cytosolic domain was analyzed. Results 
showed that this chimera was also localized on both plasma membrane 
and mitochondria (Fig. 13). 
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Fig. 12  Western blot of differential protein extracts from BHK expressing the chimeric 
proteins NCX1/NCX3 788-829 or NCX1/NCX3 718-795. 
Fig. 13  Western blot of differential protein extracts from BHK expressing the chimeric 
protein NCX1/NCX3 718-780. 
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5.3   Analysis of subcellular localization of CBD1 or CBD2 
domains of NCX3 
Western blot experiment on subcellular fractions from BHK cells 
transfected with the plasmids expressing the NCX3 sub-domains CBD1 
and CBD2 fused with EGFP showed no mitochondrial localization as 
well (Fig. 14 A). By contrast, EGFP alone did not show mitochondrial 
localization (Fig. 14 B). 
Results obtained excluded that these regions are involved in the 
mitochondrial localization of NCX3. 
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Fig. 14 B Western blot of differential protein extracts from BHK expressing the EGFP  
Fig. 14 A Western blot of differential protein extracts from BHK expressing the EGFP 
fused with the sub domains CBD1 or CBD2 of NCX3 protein. 
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5.4       Identification of mitochondrial chimeric targeting signals 
in NCX3 
Western blot analysis on plasma membrane and mitochondrial fractions, 
obtained from BHK cells stably transfected with the wild type form of 
NCX3 and treated with the PKA inhibitor KT5720, was performed to 
evaluate the involvement of a PKA-mediated mechanism of activation of 
mitochondrial chimeric targeting signals in NCX3. The efficiency of the 
inhibitor was primary tested on BHK cells assessing the expression of 
the main molecular target of PKA, the cAMP response element-binding 
protein (CREB) and its phosphorylated form (pCREB). The results 
obtained demonstrated that, although the CREB/p-CREB 
phosphorylation rate was decreased (Fig 15 A), the PKA activity 
inhibition did not show interference with subcellular targeting of NCX3 
in plasmamembrane and mitochondrial compartments, compared to the 
control cells (Fig. 15 B).  
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Fig. 15 A.  Western blot analysis of CREB/pCREB ratio in total extracts from BHK cells 
treated with  1μM of KT5720 for 24h. 
Fig. 15 B Western blot analysis of subcellular localization of NCX3 in BHK cells 
transiently expressing NCX3 (CTL) and treated with KT5720 1μM for 24h. 
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The mutant exchanger NCX3Δ2-31 displayed an increased ratio in 
mitochondrial localization normalized for VDAC, as compared to the 
control cells (Fig. 16).  
 
 
 
  
CTL Δ2-31
N
C
X
3
 /
 A
C
T
 R
a
te
(%
 o
f
C
o
n
tr
o
l)
NCX3 
CTL
NCX3 
Δ2-31
0
50
100
150
200
N
C
X
3
 /
 V
D
A
C
 
R
a
te
(%
 o
f
C
o
n
tr
o
l)
(* vs CTL)
NCX3 
CTL
NCX3 
Δ2-31
0
50
100
150
200
*
CTL Δ2-31
Actin (42kDa) 
NCX3 (105 Kda)
Actin (42kDa) 
NCX3 (105 Kda)
Plasma Membrane Mitochondria
N
C
X
3
/A
C
T 
R
at
io
CTL Δ2-31
N
C
X
3
 /
 A
C
T
 R
a
te
(%
 o
f
C
o
n
tr
o
l)
NCX3 
CTL
NCX3 
Δ2-31
0
50
100
150
200
N
C
X
3
 /
 V
D
A
C
 
R
a
te
(%
 o
f
C
o
n
tr
o
l)
(* vs CTL)
NCX3 
CTL
NCX3 
Δ2-31
0
50
100
150
200
*
CTL Δ2-31
Actin (42kDa) 
NCX3 (105 Kda)
Actin (42kDa) 
NCX3 (105 Kda)
Plasma Membrane Mitochondria
N
C
X
3
/V
D
A
C
  R
a
ti
o
(%
 o
f
C
o
n
tr
o
l)
NC 3 NC Δ2-31 3 NC
Δ2-31
(*vs CTL)
Fig. 16  Western blot analysis of NCX3 (CTL) and NCX3 lacking the first 30 
amino acids (NCX3Δ2-31) stably expressed in BHK cells.  
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5.5 Silencing experiment of the mitochondrial outer receptors 
Western blot on BHK cells treated with siTOM20, siTOM22 or 
siTOM70 showed that these mitochondrial receptors significantly 
decreased at 48h from the siRNA transfection (Fig. 17). 
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Fig. 17  Effect of the silencing by RNA interference of the mitochondrial outer 
membrane receptor TOM20, TOM22 or TOM70 in BHK cells. 
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The silencing of TOM22 or TOM70 was caused a decrease of NCX3 
immunosignal on mitochondrial fraction as compared to BHK cells 
transfected with untargeted siRNA (Fig. 18). By contrast, the silencing 
of the mitochondrial receptor TOM20 did not affect the amount of 
NCX3 on mitochondrial fraction (Fig. 12). 
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Fig. 18  NCX3 expression on mitochondria of BHK cells after RNA interference of 
TOM20, TOM22 or TOM70 receptors.  
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6.    DISCUSSION 
In this study, we found for the first time the mechanisms involved in the 
recognition and import of NCX3on mitochondria. 
The most interesting results we obtained is the presence of multiple 
mitochondrial localization signals spread along the entire sequence of 
NCX3 antiporter as it occurs in other proteins present on the outer 
mitochondrial membrane (78; 79; 80; 81; 82). Our data showed that 
these signals are localized at the amino terminus, 109-133aa 
corresponding to the 1 repeat, at the carboxy terminus, 788-829aa 
corresponding to the 2 repeat, and at the C-terminal portion of the f-
loop, 718-787aa. Interestingly, each identified amino acid regions was 
able to localize NCX1 on mitochondria suggesting that these 
mitochondrial targeting signals do not form a unique recognizable 
structure. 
Another aspect that deserves consideration is that the first mitochondrial 
signal of NCX3,1, is close to a signal peptide that is cleaved during the 
protein maturation, as it occursin other proteins with multiple subcellular 
localizations. Furthermore, this signal peptide for the plasma membrane 
localization seemed to be competitive with mitochondrial localization 
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sequences present on NCX3. Indeed, the removal of the signal peptide, 
by using a deletion mutant of NCX3, NCX3
2-31
, increased the amount of 
the antiporter on mitochondria. These data strongly suggest that NCX3 is 
provided with a chimeric localization signal that might be controlled by 
regulating the endoproteolytic cleavage of its signal peptide as it occurs 
in other proteins with multiple subcellular localizations. It is possible to 
speculate that this might represent a mechanism for the regulation of the 
Ca
2+
 homeostasis under physiological and pathophysiological conditions, 
indeed, NCX3 can reorganize its subcellular localization depending on 
several physiological and pathological conditionshelping cells to recover 
basal conditionsas demonstrated in previous papers (59). 
Another interesting finding emerging from our studies is the 
participation of both mitochondrial receptors Tom70 and Tom22 in the 
import of NCX3 on mitochondria. In fact, the silencing of either Tom70 
or Tom22 causes a significant decrease in NCX3 localization on 
mitochondria. The requirement of both mitochondrial receptors is not 
surprising because Tom70 is mainly involved in the recognition of 
precursor proteins targeted to mitochondria provided with multiple 
transmembrane α-helical segments (81) as NCX3, whereas Tom22 is 
mainly involved in the transfer of the pre-protein on the outer 
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mitochondrial membrane (88; 84).In addition, our results showed that 
the recognition of NCX3 by the mitochondrial import machinery was not 
affected by a PKA-dependent phosphorylation as it occurs for several 
mitochondrial proteins. 
Although further experiments are needed to characterize the regulation 
of the subcellular localization of NCX3, we can hypothesize this 
mechanism might affect the subcellular ionic homeostasis and thus the 
cellular function and vitality. 
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